Tokyo/New York — July 1, 2026. SoftBank Group has restarted negotiations with a lender consortium for a $10 billion margin loan collateralized by its stake in OpenAI, sweetening terms with fresh concessions after the same facility stalled in June at a slimmed-down $6 billion, according to Reuters and Bloomberg. The revived talks target the original size and, if closed, would rank among the largest ever margin loans secured against a stake in a private company.
What is being financed
A margin loan is, in essence, a securities-backed loan: the borrower pledges shares as collateral, and the lender advances cash at a discount to their market value. In public markets, the structure is routine — brokers extend credit under Regulation T at haircuts set by the Federal Reserve. What makes the SoftBank deal unusual is the collateral: shares in OpenAI, a private company that does not trade on an exchange and has no daily mark. Lenders instead rely on the latest primary funding round to set a reference price and apply a conservative loan-to-value ratio.
SoftBank is the largest outside backer of OpenAI. Founder Masayoshi Son has publicly committed to making the AI lab the centerpiece of the group’s next-generation portfolio, and CEO Sam Altman has continued to anchor negotiations around a $1 trillion valuation ceiling.
A stop-start facility
The current $10 billion push is the third act in a facility that has been in the market since spring. Talks began this year targeting a full $10 billion; by June, creditor pushback had trimmed the ask to $6 billion; a fortnight later, discussions stalled entirely. The July 1 restart returns to the original size but adds lender-friendly concessions — tighter collateral coverage tests, faster margin-call triggers, and additional restrictions on SoftBank’s ability to pledge the same OpenAI shares elsewhere.
| Date | Development | Target size |
|---|---|---|
| March 2026 | SoftBank draws a bridge facility to fund a second $10B tranche into OpenAI via Vision Fund 2 | $10.0B |
| May 2026 | Initial margin-loan negotiations begin with Goldman Sachs, JPMorgan and Mizuho | $10.0B |
| June 2026 | Creditor pushback shrinks the ask; talks then stall | $6.0B |
| July 1, 2026 | SoftBank restarts talks at full size with added concessions | $10.0B |
Why lenders were reluctant
Private-stake margin loans compress two independent risks — leverage risk and mark-to-market risk — into a single trade, and both have grown harder to price this year.
- No daily mark. Because OpenAI shares do not trade, the collateral is valued by reference to primary funding rounds and secondary tender offers. When one of those inputs moves, the entire loan-to-value calculation resets in a single step rather than smoothly. Banks typically demand a wider haircut than they would on listed equity.
- Concentrated exposure. A single-name margin loan without hedges leaves the lender directly exposed to a valuation reset at OpenAI. Standard interbank hedges — index shorts, sector puts, single-stock CDS — don’t exist for a private issuer.
- Enforcement mechanics. If the loan defaults, the lender’s practical remedy is to force a sale of the collateralized shares. In a private company, that requires cooperation from OpenAI’s transfer agent and can trigger SEC Rule 144-style holding constraints for anyone in the chain.
- IPO uncertainty. An OpenAI listing would give the collateral a public price, but Altman’s timing has slid, pushing out the point at which lenders could exit cleanly.
Reported lenders include Goldman Sachs, JPMorgan and Mizuho. The three banks were also identified in earlier press reporting as arrangers on the underlying March 2026 bridge that SoftBank used to fund its second $10 billion OpenAI tranche via Vision Fund 2.
Concessions on the table
The precise terms have not been disclosed, but people familiar with the discussions told Reuters and Bloomberg that SoftBank is offering: a lower advance rate against the reference OpenAI valuation, tighter mark-based margin-call thresholds, expanded lender consent rights over additional pledges of OpenAI shares, and, in some structures, an equity kicker or higher spread over benchmark rates. Taken together, the concessions shift more of the downside risk back to SoftBank in exchange for lender participation at scale.
What this signals for capital markets
The SoftBank facility is a live case study in how the private-company financing wave is stretching traditional lender risk frameworks. Three implications stand out:
1. Private-stake collateral is becoming its own asset class.
Margin loans against holdings in private “AI unicorns” — OpenAI, Anthropic, xAI, Databricks — are increasingly common but remain bespoke. Lenders that build in-house valuation and enforcement muscle for these deals earn substantial spread; those that don’t sit on the sidelines. Expect more standardization of terms as more issuers try to replicate SoftBank’s structure.
2. IPO windows are load-bearing for private credit.
An implicit assumption behind many of these facilities is that the underlying private company will eventually list, giving the lender a clean exit. When those IPO timelines slip — as OpenAI’s has — the loans stay outstanding longer than intended and put more pressure on the mark-based margin mechanics. That, in turn, feeds back into the primary market: sponsors and issuers face pressure to accelerate listings just to service the leverage stack behind them.
3. Lender concentration risk is real.
A $10 billion single-name margin loan against a private issuer is not something a single bank can hold comfortably on-balance-sheet. Even a three-way syndicate of Goldman, JPMorgan and Mizuho takes on meaningful concentration. Watch for a follow-on syndication into hedge funds, private credit vehicles, and possibly a securitized takeout later in 2026.
What to watch next
- Facility closing. Whether the concessions are enough to clear the syndicate is likely to be resolved within weeks.
- SoftBank disclosures. Look for updated language in the group’s next quarterly disclosure to SoftBank Investor Relations about pledged assets and Vision Fund financing.
- OpenAI IPO signal. Any concrete update on an OpenAI listing timeline would materially reduce the lender risk profile on this facility — and re-open the door for larger single-name deals against private AI stakes.
Sources
- Reuters — Business/Finance
- Bloomberg — Markets
- SoftBank Group Investor Relations
- OpenAI
- Federal Reserve — Regulations index (Reg T)
- SEC — Rule 144 investor guidance
Disclosure: This article was produced with AI assistance and reviewed before publication. It is for informational purposes only and is not investment advice.